FLUCELVAX QUADRIVALENT Rx
Generic Name and Formulations:
Quadrivalent, inactivated, "subunit" influenza vaccine (virus types A and B); contains a total of 60mcg of hemagglutinin per 0.5mL dose; formulation changes annually; susp for IM inj; antibiotic-free.
Indications for FLUCELVAX QUADRIVALENT:
Adults and Children:
<4yrs: not established. Each dose is 0.5mL by IM inj once in the deltoid. 4–8yrs: 1 or 2 doses at least 4wks apart (depending on vaccination history as per annual ACIP recommendation). ≥9yrs: 1 dose.
Use current formulation only. Have appropriate medical treatment and supervision readily available. Guillain-Barre syndrome within 6 weeks of previous flu vaccine. Immunosuppressed. Pregnancy (Cat.B). Nursing mothers.
Concomitant vaccines: insufficient data (see full labeling). Immunosuppressants: may get suboptimal response.
Local reactions (eg, pain, erythema, induration), headache, fatigue, myalgia; syncope.
Single-dose prefilled syringe 0.5mL (preservative-free)—10 (without needles); Multi-dose vial 5mL (contains thimerosal)—1
Neurology Advisor Articles
- High-Dose Biotin May Be an Effective Treatment for Progressive MS
- Biobank Data Suggest Vitamin D Reduces Risk for Multiple Sclerosis
- Patients With Multiple Sclerosis Face Greater Infection Risk
- Fingolimod Compared With Glatiramer Acetate in Head-to-Head MS Study
- Lower Relapse Risk and Disability Progression With Oral DMT in Treatment-Naive RRMS
- Skills-Based Intervention Did Not Cut Systolic BP After Stroke, TIA
- High Frequency of Headaches Following Dialysis Associated With BUN and Blood Pressure
- OnabotulinumtoxinA Injections Reduce Frequency of Cluster Headaches
- Aetna-CVS Merger Approved
- Trump to Sign Bills Lifting Drug Price 'Gag Orders' on Pharmacists